The potent reverse transcriptase inhibitor Efavirenz is produced in
crystalline form. Crystalline Efavirenz exists in several physical forms
which are-designated Forms 1, 2, 3 and 4, and are characterized by x-ray
powder diffraction and differential scanning calorimetry. Pharmaceutical
compositions and methods are useful for the treatment of the human
immunodeficiency virus (HIV).